Alpha and Beta Analysis
|
|
|
 | (alpha) | = | 0.52 |  | (beta) | = | (1.19) | 30 days against S&P 500 |
| Risk Adjusted Performance 0.0276 | Jensen Alpha 0.5011 | Total Risk Alpha (2.36) | Sortino Ratio (0.03) | Treynor Ratio (0.13) |
Biostar Probability Of Bankruptcy
Biostar Pharmaceuticals Inc has less than 47.0 (%) percent chance of experiencing financial distress in the next 2 years of operations. | Biostar Market Performance
99% of all equities and portfolios perform better than Biostar Pharmaceuticals Inc. Compared with the overall equity markets, risk-adjusted returns on investments in Biostar Pharmaceuticals Inc are ranked lower than 1 (%) of all global equities and portfolios over the last 30 days. |
Biostar Return and Market MediaThe median price of Biostar for the period between Mon, Apr 22, 2013 and Wed, May 22, 2013 is 0.75 with a coefficient of variation of 7.08. The daily time series for the period is distributed with a sample standard deviation of 0.05, arithmetic mean of 0.75, and mean deviation of 0.04. The Stock received substential amount of media coverage during this period.
|
| Frequently Asked Questions Quick Product Tour Product Technology Overview Solution Methodology Plans and Pricing |
|
World Market Correlations Instant Equity Comparator Watchlist Analysis Position Suggestions Equity Alpha Analysis |
|
About Macroaxis Contact Us Product Terms Of Use Service Privacy Policy Advertising Opportunities |
0.56%
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
